Pablo Harker1, Robert W Regenhardt1, Naif M Alotaibi1,2, Justin Vranic1, Faith C Robertson1, Adam A Dmytriw3,4, Jerry C Ku5, Matthew Koch1, Christopher J Stapleton1, Thabele M Leslie-Mazwi1, Nelson Serna6, Boris Pabon6, Juan A Mejia6, Aman B Patel1. 1. Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Neuroendovascular Program, 55 Fruit St, WAC 745, Boston, MA, USA. 2. Department of Neurosurgery, King Fahad Medical City, National Neuroscience Institute, Riyadh, Saudi Arabia. 3. Neuroradiology & Neurointervention Service, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. admytriw@bwh.harvard.edu. 4. Departments of Medical Imaging and Neurosurgery, University of Toronto, Toronto, ON, Canada. admytriw@bwh.harvard.edu. 5. Departments of Medical Imaging and Neurosurgery, University of Toronto, Toronto, ON, Canada. 6. AngioTeam Cerebrovascular, Endovascular Neurosurgery and Neuroradiology, Medellin, Colombia.
Abstract
PURPOSE: The Woven EndoBridge (WEB) can be used to treat wide-necked aneurysms without antiplatelet medications, suggesting it may have advantages in the setting of aneurysmal subarachnoid hemorrhage (aSAH). The goal was assessment of safety and efficacy of WEB in aSAH given the delayed nature of aneurysmal thrombosis. METHODS: An international retrospective analysis of patients with aSAH treated with WEB was conducted at 7 tertiary centers from 2016 to 2020. Outcomes included rates of rebleeding, retreatment, complications, and complete occlusion. Furthermore, a systematic review and meta-analysis was conducted from 2011 to 2020 assessing the same outcomes. All pooled event rates were calculated using a random effect model. RESULTS: Consecutive patients with aSAH harbored 25 aneurysms that were treated with 29 WEB devices. The mean age was 53 years, and 65% were female. Zero experienced rebleeding, 2 were retreated, 2 experienced complications, 16 were completely occluded at 3 months, and 21 were completed occluded at 9-12 months. Meta-analysis of 309 WEB treatments for aSAH from 7 case series revealed 2.5% (95% CI 1-5%) had rebleeding, 9% (95% CI 4-17%) were retreated, 17% (95% CI 10-30%) had complications, and 61% (95% CI 51-71%) were completely occluded at 3-6 months. CONCLUSION: WEB embolization in the setting of aSAH provides similar protection against rebleeding with comparable retreatment rates to traditional approaches. However, there is a higher rate of incomplete radiographic occlusion and operative complications compared to WEB embolization of unruptured aneurysms. Long-term prospective studies are needed to fully delineate the role of WEB embolization in aSAH.
PURPOSE: The Woven EndoBridge (WEB) can be used to treat wide-necked aneurysms without antiplatelet medications, suggesting it may have advantages in the setting of aneurysmal subarachnoid hemorrhage (aSAH). The goal was assessment of safety and efficacy of WEB in aSAH given the delayed nature of aneurysmal thrombosis. METHODS: An international retrospective analysis of patients with aSAH treated with WEB was conducted at 7 tertiary centers from 2016 to 2020. Outcomes included rates of rebleeding, retreatment, complications, and complete occlusion. Furthermore, a systematic review and meta-analysis was conducted from 2011 to 2020 assessing the same outcomes. All pooled event rates were calculated using a random effect model. RESULTS: Consecutive patients with aSAH harbored 25 aneurysms that were treated with 29 WEB devices. The mean age was 53 years, and 65% were female. Zero experienced rebleeding, 2 were retreated, 2 experienced complications, 16 were completely occluded at 3 months, and 21 were completed occluded at 9-12 months. Meta-analysis of 309 WEB treatments for aSAH from 7 case series revealed 2.5% (95% CI 1-5%) had rebleeding, 9% (95% CI 4-17%) were retreated, 17% (95% CI 10-30%) had complications, and 61% (95% CI 51-71%) were completely occluded at 3-6 months. CONCLUSION: WEB embolization in the setting of aSAH provides similar protection against rebleeding with comparable retreatment rates to traditional approaches. However, there is a higher rate of incomplete radiographic occlusion and operative complications compared to WEB embolization of unruptured aneurysms. Long-term prospective studies are needed to fully delineate the role of WEB embolization in aSAH.
Authors: Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman Journal: Lancet Date: 2002-10-26 Impact factor: 79.321
Authors: Cameron G McDougall; Robert F Spetzler; Joseph M Zabramski; Shahram Partovi; Nancy K Hills; Peter Nakaji; Felipe C Albuquerque Journal: J Neurosurg Date: 2011-11-04 Impact factor: 5.115
Authors: Ning Lin; Kevin S Cahill; Kai U Frerichs; Robert M Friedlander; Elizabeth B Claus Journal: J Neurointerv Surg Date: 2011-06-23 Impact factor: 5.836
Authors: L Pierot; T Liebig; V Sychra; K Kadziolka; F Dorn; C Strasilla; C Kabbasch; J Klisch Journal: AJNR Am J Neuroradiol Date: 2012-06-07 Impact factor: 3.825
Authors: R S Bechan; M E Sprengers; C B Majoie; J P Peluso; M Sluzewski; W J van Rooij Journal: AJNR Am J Neuroradiol Date: 2015-09-24 Impact factor: 3.825
Authors: Visish M Srinivasan; Adam A Dmytriw; Robert W Regenhardt; Juan Vicenty-Padilla; Naif M Alotaibi; Elad Levy; Muhammad Waqas; Jacob Cherian; Jeremiah N Johnson; Pascal Jabbour; Ahmad Sweid; Bradley Gross; Robert M Starke; Ajit Puri; Francesco Massari; Christoph J Griessenauer; Joshua S Catapano; Caleb Rutledge; Omar Tanweer; Parham Yashar; Gustavo M Cortez; Mohammad A Aziz-Sultan; Aman B Patel; Andrew F Ducruet; Felipe C Albuquerque; Ricardo A Hanel; Michael T Lawton; Peter Kan Journal: Neurosurgery Date: 2022-05-01 Impact factor: 5.315